Targeting ticagrelor: a novel therapy for emergency reversal

Newer P2Y12 inhibitors are prescribed in place of clopidogrel for patients with acute coronary syndrome (ACS) and are associated with significant bleeding risks. Currently, limited options exist for the management of life-threatening bleeding or acute reversal for patients on P2Y12 inhibitor therapy...

Full description

Saved in:
Bibliographic Details
Published in:Ann Transl Med
Main Authors: Cave, Brandon, Rawal, Aranyak, Ardeshna, Devarshi, Ibebuogu, Uzoma N., Sai-Sudhakar, Chittoor B., Khouzam, Rami N.
Format: Artigo
Language:Inglês
Published: AME Publishing Company 2019
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6787384/
https://ncbi.nlm.nih.gov/pubmed/31660309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.08.08
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items